Bausch + Lomb Corporation

Bausch + Lomb Corporation is a global eye health company that develops, manufactures, and markets a wide range of products to support eye health. The company operates through three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment offers contact lenses in various wearing modalities, including daily disposable and frequently replaced lenses, as well as contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops for conditions like allergies, dry eye, and redness relief. The Pharmaceuticals segment provides proprietary and generic prescription drugs for post-operative care, glaucoma, eye inflammation, dry eye, and retinal diseases. The Surgical segment supplies medical devices, consumables, and technologies for cataract, corneal, vitreous, and retinal surgeries, including intraocular lenses and phacoemulsification equipment.

Bausch + Lomb Corporation is listed on the New York Stock Exchange (NYSE) under the ticker symbol BLCO. Its shares are traded in US Dollars (USD). The company is headquartered in Vaughan, Canada, but its stock is listed on a major US exchange, providing access to a broad base of international investors.

Bausch + Lomb Corporation operates in the Healthcare sector and is classified under the Medical Instruments & Supplies industry. This industry includes companies that manufacture medical devices, instruments, and consumables used in healthcare settings. Bausch + Lomb specifically focuses on eye health, producing contact lenses, surgical equipment for cataract and retinal procedures, and pharmaceutical treatments for various eye conditions.

Bausch + Lomb Corporation is headquartered in Vaughan, Canada, and operates globally. The company sells its products through direct sales forces and independent distributors, serving customers worldwide. Its products address a wide range of eye health needs, from everyday vision correction with contact lenses to advanced surgical solutions for cataracts and retinal diseases. The company's global reach allows it to serve patients, eye care professionals, and healthcare providers across multiple regions.

Bausch + Lomb generates revenue through three main business segments. The Vision Care segment sells contact lenses, lens care products, and over-the-counter eye drops, earning income from both consumer and professional channels. The Pharmaceuticals segment derives revenue from prescription drugs for eye conditions such as glaucoma, dry eye, and inflammation, sold to pharmacies and healthcare providers. The Surgical segment generates revenue by selling medical devices, intraocular lenses, and equipment used in cataract and retinal surgeries to hospitals and surgical centers. This diversified model allows the company to capture value across the eye health continuum.